These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 17541959

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells.
    Culig Z, Hobisch A, Hittmair A, Cronauer MV, Radmayr C, Zhang J, Bartsch G, Klocker H.
    Prostate; 1997 Jul 01; 32(2):106-14. PubMed ID: 9215398
    [Abstract] [Full Text] [Related]

  • 24. Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells.
    Le HT, Schaldach CM, Firestone GL, Bjeldanes LF.
    J Biol Chem; 2003 Jun 06; 278(23):21136-45. PubMed ID: 12665522
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A, Fraizer GC, Piantanelli L, Saunders GF.
    Anticancer Res; 2001 Jun 06; 21(1A):1-10. PubMed ID: 11299720
    [Abstract] [Full Text] [Related]

  • 28. Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.
    Gravina GL, Festuccia C, Millimaggi D, Dolo V, Tombolini V, de Vito M, Vicentini C, Bologna M.
    Prostate; 2008 May 15; 68(7):793-801. PubMed ID: 18324645
    [Abstract] [Full Text] [Related]

  • 29. HEXIM1 plays a critical role in the inhibition of the androgen receptor by anti-androgens.
    Yeh IJ, Song K, Wittmann BM, Bai X, Danielpour D, Montano MM.
    Biochem J; 2014 Sep 01; 462(2):315-27. PubMed ID: 24844355
    [Abstract] [Full Text] [Related]

  • 30. Prospective identification of tumorigenic prostate cancer stem cells.
    Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ.
    Cancer Res; 2005 Dec 01; 65(23):10946-51. PubMed ID: 16322242
    [Abstract] [Full Text] [Related]

  • 31. Antagonistic interaction between bicalutamide (Casodex) and radiation in androgen-positive prostate cancer LNCaP cells.
    Quéro L, Giocanti N, Hennequin C, Favaudon V.
    Prostate; 2010 Mar 01; 70(4):401-11. PubMed ID: 19902473
    [Abstract] [Full Text] [Related]

  • 32. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
    Yan J, Xie B, Capodice JL, Katz AE.
    Prostate; 2012 Feb 01; 72(3):244-52. PubMed ID: 21656835
    [Abstract] [Full Text] [Related]

  • 33. The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation.
    Garay JP, Karakas B, Abukhdeir AM, Cosgrove DP, Gustin JP, Higgins MJ, Konishi H, Konishi Y, Lauring J, Mohseni M, Wang GM, Jelovac D, Weeraratna A, Sherman Baust CA, Morin PJ, Toubaji A, Meeker A, De Marzo AM, Lewis G, Subhawong A, Argani P, Park BH.
    Breast Cancer Res; 2012 Feb 09; 14(1):R27. PubMed ID: 22321971
    [Abstract] [Full Text] [Related]

  • 34. Androgen receptor-mediated repression of novel target genes.
    Prescott J, Jariwala U, Jia L, Cogan JP, Barski A, Pregizer S, Shen HC, Arasheben A, Neilson JJ, Frenkel B, Coetzee GA.
    Prostate; 2007 Sep 15; 67(13):1371-83. PubMed ID: 17624924
    [Abstract] [Full Text] [Related]

  • 35. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
    Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S, Sesterhenn IA, McLeod DG, Srivastava S, Rhim JS.
    Cancer Res; 2007 Apr 01; 67(7):3153-61. PubMed ID: 17409422
    [Abstract] [Full Text] [Related]

  • 36. Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.
    Liu X, Choi RY, Jawad SM, Arnold JT.
    Prostate; 2011 May 15; 71(7):766-77. PubMed ID: 21031436
    [Abstract] [Full Text] [Related]

  • 37. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
    Arnold JT, Liu X, Allen JD, Le H, McFann KK, Blackman MR.
    Prostate; 2007 Aug 01; 67(11):1152-62. PubMed ID: 17503469
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.